The latest reported IMD incidence rates in France point toward an increasing trend [ 86 ], highlighting the need to interpret the model’s results in light of the current epidemiological situation.
← all excerpts
Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France.
1
—
—